Are fas ligand polymorphisms associated with occult HBV infection?

Laboratory Medicine

Volumn 41, Issue 11, 2010, Pages 672-675

  Arababadi, Mohammad Kazemi ^a   Mohammadzadeh, Adel ^b   Ahmadabadi, Behzad Nasiri ^a   Pourfathollah, Ali Akbar ^b   Kennedy, Derek ^c  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

FasL; HBsAg; HBV DNA; Occult hepatitis B infection; Polymorphism

Indexed keywords

FAS LIGAND; GENOMIC DNA; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

HEPATITIS B VIRUS;

EID: 78449262156     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LM7CH48RQRLRDLDZ     Document Type: Article

References (20)

1. Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al. Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in southeastern Iranian patients. J Gastroen Hepatol. 2010;25:90-93.
2. Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al. Serum levels of Interleukin (IL)-10 and IL-17A in occult HBV infected south-east Iranian patients. Hepat Mon. 2010;10:31-35.
3. Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al. Peripheral blood CD8+ T cells CCR5 expression and its Δ32 mutation in Iranian patients with occult hepatitis B infections. LabMed. 2010;41:226-230.
4. Jafarzadeh A, Arababadi MK, Mirzaee M, et al. Occult hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Acta Med Iran. 2008;46:27-32.
5. Pourazar A, Salehi M, Jafarzadeh A, et al. Detection of HBV DNA in HBsAg negative normal blood donors. Iran J Immunol. 2005;2:172-176.
6. Demir M, Serin E, Göktürk S, et al. The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients. Eur J Gastroenterol Hepatol. 2008;20:668-673.
7. Zerbini A, Pilli M, Boni C, et al. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology. 2008;134:1470-1481.
8. Bortolami M, Kotsafti A, Cardin R, et al. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease. J Viral Hepat. 2008;15:515-522.
9. Jun EJ, Han JY, Sun HS. Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B. Korean J Hepatol. 2006;12:507-514.
10. Hayashi N, Mita E. Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J Viral Hepat. 1999;6:357-365.
11. Nasi M, Pinti M, Bugarini R, et al. Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naive HIV-positive patients. Immunogenetics. 2005;57:628-635.
12. Zhang Z, Wang LE, Sturgis EM, et al. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006;12:5596-5602.
13. Shin EC, Shin JS, Park JH, et al. Expression of fas ligand in human hepatoma cell lines: Role of hepatitis-B virus X (HBX) in induction of Fas ligand. Int J Cancer. 1999;82:587-591.
14. Kim SS, Hong SJ, Ahn YG, et al. Apo-1/Fas (CD95) gene polymorphism in Korean hepatocellular carcinoma patients. Korean J Physiol Pharmacol. 2003;7:29-31.
15. Jung YJ, Kim YJ, Kim LH, et al. Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection. Intervirology. 2007;50:369-376.
16. Dmitrieva EV, Moskaleva E, Kogan EA, et al. The role of Fas/FasL system in induction of hepatocyte apoptosis in chronic viral hepatitides. Arkh Patol. 2003;65:13-17.
17. Takahashi T, Tanaka M, Inazawa J, et al. Human Fas ligand: Gene structure, chromosomal location and species specificity. Int Immunol. 1994;6:1567-1574.
18. Aguilar-Reina J, Ruiz-Ferrer M, Pizarro MA, et al. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C. J Viral Hepat. 2005;12:568-573.
19. Ruiz-Ferrer M, Antiñolo G, Aguilar-Reina J. Analysis of the -844C > T polymorphism in the promoter region of FASLgene in a cohort of Spanish HCV patients. J Viral Hepat. 2007;14:293-294.
20. McIlroy D, Théodorou I, Ratziu V, et al. FAS promoter polymorphisms correlate with activity grade in hepatitis C patients. Eur J Gastroenterol Hepatol. 2005;17:1081-1088.